Free shipping on all orders over $ 500

Lersivirine

Cat. No. M3743
Lersivirine Structure
Synonym:

UK-453061

Size Price Availability Quantity
5mg USD 103.5  USD115 In stock
10mg USD 171  USD190 In stock
50mg USD 594  USD660 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Lersivirine is a potent enzyme inducer in rodents capable of inducing a number of hepatic enzymes including those involved in its own metabolism. Preclinically lersivirine has been associated with hepatocellular hypertrophy and thyroid gland follicular cell hypertrophy in rats, mice, and dogs. Lersivirine has therapeutic potential for HIV-infected individuals with viral strains resistant against first-line NNRTIs. However, no large, well-powered studies have been conducted so far, which assess noninferiority against established antiretroviral agents. Lersivirine 750 mg and 1,000 mg qd was associated with lower rates of viral suppression at week 24 and week 48 versus etravirine in patients with prior NNRTI use and evidence of NNRTI resistance. No new safety signals were detected.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 310.35
Formula C17H18N4O2
CAS Number 473921-12-9
Purity >98%
Solubility DMSO
Storage at -20°C
References

Efficacy and safety of lersivirine versus etravirine for the treatment of HIV-1 infection in patients with prior non-nucleoside reverse transcriptase inhibitor (NNRTI) use and evidence of NNRTI resistance: a randomized phase 2B trial.
DeJesus E, et al. HIV Clin Trials. 2014 Sep-Oct;15(5):209-17. PMID: 25350959.

Effects of Lersivirine on Canine and Rodent Thyroid Function.
Houle CD, et al. Toxicol Pathol. 2013 Oct 16;42(5):897-912. PMID: 24135463.

Lersivirine - a new drug for HIV infection therapy.
Platten M, et al. Expert Opin Investig Drugs. 2013 Dec;22(12):1687-94. PMID: 24128277.

Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
Vourvahis M, et al. Drug Alcohol Depend. 2012 Nov 1;126(1-2):183-8. PMID: 22682979.

Related HIV Protease Products
Cabotegravir

Cabotegravir, also known as S/GSK1265744 or GSK744, is potent HIV integrase inhibitor.

Tenofovir hydrate

Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.

Diphyllin

Diphyllin is an arylnaphthalene lignan isolated from Justicia procumbens and is a potent HIV-1 inhibitor with an IC50 of 0.38 μM.

Diethyldithiocarbamate sodium

Sodium diethyldithiocarbamate is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.

Apelin-36(rat, mouse) TFA

Apelin-36(rat, mouse) TFA is an endogenous orphan G protein-coupled receptor APJ agonist.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: Lersivirine, UK-453061 supplier, HIV Protease, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.